Aflatoxin B-1 binding by a mixture of Lactobacillus and Propionibacterium

In vitro versus ex vivo

Silvia Gratz, H Mykkanen, H El-Nezami

Research output: Contribution to journalArticle

Abstract

Aflatoxin B-1 (AFB(1)) is a well-known carcinogen and reducing its bioavailability is of great interest for human and animal health. Several probiotic bacteria are able to bind AFB(1) in vitro, including Lactobacillus rhamnosus LC-705 and Propionibacterium freudenreichii subsp. shermanii JS. A mixture of these two probiotics is used by the food and feed industry as biopreservative (Bioprofit), making it a promising candidate for future applications. Consequently, this study aims to investigate the in vitro and ex vivo ability of this probiotic mixture to bind AFB(1). For in vitro experiments, probiotic mixture was suspended in an AFB(1) solution (5 mu M), incubated for 1 to 30 min, centrifuged, and AFB(1) residues were quantitated in supernatant and pellet. For ex vivo experiments, duodenal loops of chicks were ligated and injected with either AFB(1) solution alone or probiotic mixture suspension and AFB(1) solution. Lumen content was centrifuged and AFB(1) was quantitated in supernatant and pellet. Additionally, AFB(1) was extracted from duodenal tissue to calculate tissue uptake. In vitro, 57 to 66% of AFB(1) was removed from the solution by the probiotic mixture, but only 38 to 47% could be extracted from the bacterial surface. In ex vivo experiments, only up to 25% of AFB(1) was bound by bacteria, and tissue uptake of AFB(1) was significantly reduced when probiotic bacteria were present in the duodenal loop. Furthermore, the effect of intestinal mucus on the bacterial binding ability was investigated in vitro and was found to significantly reduce AFB(1) binding by the probiotic mixture. However, probiotic mixture could only retard but not prevent AFB(1) absorption in duodenal loops. Further work needs to assess the potential of probiotics in different experimental setups.

Original languageEnglish
Pages (from-to)2470-2474
Number of pages5
JournalJournal of Food Protection
Volume68
Issue number11
Publication statusPublished - Nov 2005

Keywords

  • lactic acid bacteria
  • intestinal mucus
  • B-1
  • ability
  • strains
  • GG

Cite this

Aflatoxin B-1 binding by a mixture of Lactobacillus and Propionibacterium : In vitro versus ex vivo. / Gratz, Silvia; Mykkanen, H ; El-Nezami, H .

In: Journal of Food Protection, Vol. 68, No. 11, 11.2005, p. 2470-2474.

Research output: Contribution to journalArticle

@article{375dbec8141143f38adc316fac250cfd,
title = "Aflatoxin B-1 binding by a mixture of Lactobacillus and Propionibacterium: In vitro versus ex vivo",
abstract = "Aflatoxin B-1 (AFB(1)) is a well-known carcinogen and reducing its bioavailability is of great interest for human and animal health. Several probiotic bacteria are able to bind AFB(1) in vitro, including Lactobacillus rhamnosus LC-705 and Propionibacterium freudenreichii subsp. shermanii JS. A mixture of these two probiotics is used by the food and feed industry as biopreservative (Bioprofit), making it a promising candidate for future applications. Consequently, this study aims to investigate the in vitro and ex vivo ability of this probiotic mixture to bind AFB(1). For in vitro experiments, probiotic mixture was suspended in an AFB(1) solution (5 mu M), incubated for 1 to 30 min, centrifuged, and AFB(1) residues were quantitated in supernatant and pellet. For ex vivo experiments, duodenal loops of chicks were ligated and injected with either AFB(1) solution alone or probiotic mixture suspension and AFB(1) solution. Lumen content was centrifuged and AFB(1) was quantitated in supernatant and pellet. Additionally, AFB(1) was extracted from duodenal tissue to calculate tissue uptake. In vitro, 57 to 66{\%} of AFB(1) was removed from the solution by the probiotic mixture, but only 38 to 47{\%} could be extracted from the bacterial surface. In ex vivo experiments, only up to 25{\%} of AFB(1) was bound by bacteria, and tissue uptake of AFB(1) was significantly reduced when probiotic bacteria were present in the duodenal loop. Furthermore, the effect of intestinal mucus on the bacterial binding ability was investigated in vitro and was found to significantly reduce AFB(1) binding by the probiotic mixture. However, probiotic mixture could only retard but not prevent AFB(1) absorption in duodenal loops. Further work needs to assess the potential of probiotics in different experimental setups.",
keywords = "lactic acid bacteria, intestinal mucus, B-1, ability, strains, GG",
author = "Silvia Gratz and H Mykkanen and H El-Nezami",
year = "2005",
month = "11",
language = "English",
volume = "68",
pages = "2470--2474",
journal = "Journal of Food Protection",
issn = "0362-028X",
publisher = "International Association for Food Protection",
number = "11",

}

TY - JOUR

T1 - Aflatoxin B-1 binding by a mixture of Lactobacillus and Propionibacterium

T2 - In vitro versus ex vivo

AU - Gratz, Silvia

AU - Mykkanen, H

AU - El-Nezami, H

PY - 2005/11

Y1 - 2005/11

N2 - Aflatoxin B-1 (AFB(1)) is a well-known carcinogen and reducing its bioavailability is of great interest for human and animal health. Several probiotic bacteria are able to bind AFB(1) in vitro, including Lactobacillus rhamnosus LC-705 and Propionibacterium freudenreichii subsp. shermanii JS. A mixture of these two probiotics is used by the food and feed industry as biopreservative (Bioprofit), making it a promising candidate for future applications. Consequently, this study aims to investigate the in vitro and ex vivo ability of this probiotic mixture to bind AFB(1). For in vitro experiments, probiotic mixture was suspended in an AFB(1) solution (5 mu M), incubated for 1 to 30 min, centrifuged, and AFB(1) residues were quantitated in supernatant and pellet. For ex vivo experiments, duodenal loops of chicks were ligated and injected with either AFB(1) solution alone or probiotic mixture suspension and AFB(1) solution. Lumen content was centrifuged and AFB(1) was quantitated in supernatant and pellet. Additionally, AFB(1) was extracted from duodenal tissue to calculate tissue uptake. In vitro, 57 to 66% of AFB(1) was removed from the solution by the probiotic mixture, but only 38 to 47% could be extracted from the bacterial surface. In ex vivo experiments, only up to 25% of AFB(1) was bound by bacteria, and tissue uptake of AFB(1) was significantly reduced when probiotic bacteria were present in the duodenal loop. Furthermore, the effect of intestinal mucus on the bacterial binding ability was investigated in vitro and was found to significantly reduce AFB(1) binding by the probiotic mixture. However, probiotic mixture could only retard but not prevent AFB(1) absorption in duodenal loops. Further work needs to assess the potential of probiotics in different experimental setups.

AB - Aflatoxin B-1 (AFB(1)) is a well-known carcinogen and reducing its bioavailability is of great interest for human and animal health. Several probiotic bacteria are able to bind AFB(1) in vitro, including Lactobacillus rhamnosus LC-705 and Propionibacterium freudenreichii subsp. shermanii JS. A mixture of these two probiotics is used by the food and feed industry as biopreservative (Bioprofit), making it a promising candidate for future applications. Consequently, this study aims to investigate the in vitro and ex vivo ability of this probiotic mixture to bind AFB(1). For in vitro experiments, probiotic mixture was suspended in an AFB(1) solution (5 mu M), incubated for 1 to 30 min, centrifuged, and AFB(1) residues were quantitated in supernatant and pellet. For ex vivo experiments, duodenal loops of chicks were ligated and injected with either AFB(1) solution alone or probiotic mixture suspension and AFB(1) solution. Lumen content was centrifuged and AFB(1) was quantitated in supernatant and pellet. Additionally, AFB(1) was extracted from duodenal tissue to calculate tissue uptake. In vitro, 57 to 66% of AFB(1) was removed from the solution by the probiotic mixture, but only 38 to 47% could be extracted from the bacterial surface. In ex vivo experiments, only up to 25% of AFB(1) was bound by bacteria, and tissue uptake of AFB(1) was significantly reduced when probiotic bacteria were present in the duodenal loop. Furthermore, the effect of intestinal mucus on the bacterial binding ability was investigated in vitro and was found to significantly reduce AFB(1) binding by the probiotic mixture. However, probiotic mixture could only retard but not prevent AFB(1) absorption in duodenal loops. Further work needs to assess the potential of probiotics in different experimental setups.

KW - lactic acid bacteria

KW - intestinal mucus

KW - B-1

KW - ability

KW - strains

KW - GG

M3 - Article

VL - 68

SP - 2470

EP - 2474

JO - Journal of Food Protection

JF - Journal of Food Protection

SN - 0362-028X

IS - 11

ER -